Article Details

Boehringer Ingelheim, IBM to study blockchain in clinical trials

Retrieved on: 2019-02-12 23:45:00

Tags for this article:

Click the tags to see associated articles and topics

Boehringer Ingelheim, IBM to study blockchain in clinical trials. View article details on hiswai:

Excerpt

<div>A privately held German drugmaker and one of the world's largest technology companies plan to work together to integrate <b>blockchain</b> into clinical ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up